-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroSense prepares Canada new drug submission for PrimeC, targets December 2026 filing

PUBT·08/13/2026 13:31:43
Listen to the news
NeuroSense prepares Canada new drug submission for PrimeC, targets December 2026 filing
  • NeuroSense began preparing a New Drug Submission to Health Canada for ALS drug PrimeC, targeting a December 2026 filing.
  • Filing plan follows pre-NDS discussions, drawing on Phase 2b PARADIGM clinical and biomarker data.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN25906) on August 13, 2026, and is solely responsible for the information contained therein.